Annexin A3 Knockdown Suppresses Lung Adenocarcinoma

Our previous study identified an elevated abundance of annexin A3 (Anxa3) as a novel prognostic biomarker of lung adenocarcinoma (LADC) through quantitative proteomics analysis. However, the biological functions of Anxa3 in LADC are not fully clear. In this study, in vitro and in vivo assays were pe...

Full description

Saved in:
Bibliographic Details
Main Authors: Ying-Fu Liu, Qing-Qing Liu, Yue-Hua Zhang, Jing-Hua Qiu
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.1155/2016/4131403
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849387256790384640
author Ying-Fu Liu
Qing-Qing Liu
Yue-Hua Zhang
Jing-Hua Qiu
author_facet Ying-Fu Liu
Qing-Qing Liu
Yue-Hua Zhang
Jing-Hua Qiu
author_sort Ying-Fu Liu
collection DOAJ
description Our previous study identified an elevated abundance of annexin A3 (Anxa3) as a novel prognostic biomarker of lung adenocarcinoma (LADC) through quantitative proteomics analysis. However, the biological functions of Anxa3 in LADC are not fully clear. In this study, in vitro and in vivo assays were performed to investigate the effects of Anxa3 downregulation on the growth, migration, invasion, metastasis, and signaling pathway activation of LADC cells. After Anxa3 downregulation, the growth of A549 and LTEP-a2 LADC cells was slowed and they showed decreased migration and invasion in vitro. Anxa3 knockdown significantly inhibited tumor formation by A549 cells in vivo; while many metastases were formed by control A549 cells, there were obvious reductions in the numbers of lung, liver, and brain metastases formed by Anxa3 knockdown in A549 cells. Furthermore, Anxa3 knockdown significantly decreased MMP-2 and N-cadherin expression and increased E-cadherin expression both in cell lines in vitro and in tumor nodules examined during in vivo tumorigenesis assays. Interestingly, Anxa3 downregulation reduced the phosphorylated levels of MEK and ERK. In summary, Anxa3 knockdown inhibited the growth, migration, invasion, and metastasis of LADC, decreased the activation of the MEK/ERK signaling pathway, and modulated the expression of MMP-2, E-cadherin, and N-cadherin.
format Article
id doaj-art-35c9309a783a49c8a563231a9a6b01a9
institution Kabale University
issn 2210-7177
2210-7185
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-35c9309a783a49c8a563231a9a6b01a92025-08-20T03:55:16ZengWileyAnalytical Cellular Pathology2210-71772210-71852016-01-01201610.1155/2016/41314034131403Annexin A3 Knockdown Suppresses Lung AdenocarcinomaYing-Fu Liu0Qing-Qing Liu1Yue-Hua Zhang2Jing-Hua Qiu3Department of Basic Medical Sciences, Medical College, Xiamen University, Xiamen, Fujian, ChinaDepartment of Basic Medical Sciences, Medical College, Xiamen University, Xiamen, Fujian, ChinaLaboratory Animal Center, Xiamen University, Xiamen, Fujian, ChinaDepartment of Basic Medical Sciences, Medical College, Xiamen University, Xiamen, Fujian, ChinaOur previous study identified an elevated abundance of annexin A3 (Anxa3) as a novel prognostic biomarker of lung adenocarcinoma (LADC) through quantitative proteomics analysis. However, the biological functions of Anxa3 in LADC are not fully clear. In this study, in vitro and in vivo assays were performed to investigate the effects of Anxa3 downregulation on the growth, migration, invasion, metastasis, and signaling pathway activation of LADC cells. After Anxa3 downregulation, the growth of A549 and LTEP-a2 LADC cells was slowed and they showed decreased migration and invasion in vitro. Anxa3 knockdown significantly inhibited tumor formation by A549 cells in vivo; while many metastases were formed by control A549 cells, there were obvious reductions in the numbers of lung, liver, and brain metastases formed by Anxa3 knockdown in A549 cells. Furthermore, Anxa3 knockdown significantly decreased MMP-2 and N-cadherin expression and increased E-cadherin expression both in cell lines in vitro and in tumor nodules examined during in vivo tumorigenesis assays. Interestingly, Anxa3 downregulation reduced the phosphorylated levels of MEK and ERK. In summary, Anxa3 knockdown inhibited the growth, migration, invasion, and metastasis of LADC, decreased the activation of the MEK/ERK signaling pathway, and modulated the expression of MMP-2, E-cadherin, and N-cadherin.http://dx.doi.org/10.1155/2016/4131403
spellingShingle Ying-Fu Liu
Qing-Qing Liu
Yue-Hua Zhang
Jing-Hua Qiu
Annexin A3 Knockdown Suppresses Lung Adenocarcinoma
Analytical Cellular Pathology
title Annexin A3 Knockdown Suppresses Lung Adenocarcinoma
title_full Annexin A3 Knockdown Suppresses Lung Adenocarcinoma
title_fullStr Annexin A3 Knockdown Suppresses Lung Adenocarcinoma
title_full_unstemmed Annexin A3 Knockdown Suppresses Lung Adenocarcinoma
title_short Annexin A3 Knockdown Suppresses Lung Adenocarcinoma
title_sort annexin a3 knockdown suppresses lung adenocarcinoma
url http://dx.doi.org/10.1155/2016/4131403
work_keys_str_mv AT yingfuliu annexina3knockdownsuppresseslungadenocarcinoma
AT qingqingliu annexina3knockdownsuppresseslungadenocarcinoma
AT yuehuazhang annexina3knockdownsuppresseslungadenocarcinoma
AT jinghuaqiu annexina3knockdownsuppresseslungadenocarcinoma